BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15136764)

  • 1. Gene expression profiling identifies markers of ampullary adenocarcinoma.
    Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
    Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
    Byrling J; Ghazi S; Andersson B
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Ampullary Adenocarcinoma].
    Shin DW
    Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
    Chiorean EG; Chiaro MD; Tempero MA; Malafa MP; Benson AB; Cardin DB; Christensen JA; Chung V; Czito B; Dillhoff M; Donahue TR; Dotan E; Fountzilas C; Glazer ES; Hardacre J; Hawkins WG; Klute K; Ko AH; Kunstman JW; LoConte N; Lowy AM; Masood A; Moravek C; Nakakura EK; Narang AK; Nardo L; Obando J; Polanco PM; Reddy S; Reyngold M; Scaife C; Shen J; Truty MJ; Vollmer C; Wolff RA; Wolpin BM; Rn BM; Lubin S; Darlow SD
    J Natl Compr Canc Netw; 2023 Jul; 21(7):753-782. PubMed ID: 37433437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the investigation and surgical management of resectable ampullary adenocarcinoma.
    Askew J; Connor S
    HPB (Oxford); 2013 Nov; 15(11):829-38. PubMed ID: 23458317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease.
    Stålberg SM; Silwal-Pandit L; Bastani NE; Nebdal DJH; Lingjærde OC; Skålhegg BS; Kure EH
    BMC Cancer; 2024 May; 24(1):555. PubMed ID: 38702616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
    Iacobuzio-Donahue CA; Maitra A; Shen-Ong GL; van Heek T; Ashfaq R; Meyer R; Walter K; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Am J Pathol; 2002 Apr; 160(4):1239-49. PubMed ID: 11943709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.
    Chandrasegaram MD; Gill AJ; Samra J; Price T; Chen J; Fawcett J; Merrett ND
    World J Gastrointest Oncol; 2017 Oct; 9(10):407-415. PubMed ID: 29085567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of DPC-X4: a novel mixed-type ampullary cancer cell line.
    Chai C; Tang H; Yi J; Li L; Yu C; Su Y; Miao L; Ye Z; Wang Z; Luo W; Hu J; Zhang H; Miao X; Xu H; Zhou W
    Hum Cell; 2024 Mar; 37(2):531-545. PubMed ID: 38253956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.
    Gingras MC; Covington KR; Chang DK; Donehower LA; Gill AJ; Ittmann MM; Creighton CJ; Johns AL; Shinbrot E; Dewal N; Fisher WE; ; Pilarsky C; Grützmann R; Overman MJ; Jamieson NB; Van Buren G; Drummond J; Walker K; Hampton OA; Xi L; Muzny DM; Doddapaneni H; Lee SL; Bellair M; Hu J; Han Y; Dinh HH; Dahdouli M; Samra JS; Bailey P; Waddell N; Pearson JV; Harliwong I; Wang H; Aust D; Oien KA; Hruban RH; Hodges SE; McElhany A; Saengboonmee C; Duthie FR; Grimmond SM; Biankin AV; Wheeler DA; Gibbs RA
    Cell Rep; 2016 Feb; 14(4):907-919. PubMed ID: 26804919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma.
    Jabbour SK; Mulvihill D
    Semin Radiat Oncol; 2014 Apr; 24(2):85-93. PubMed ID: 24635865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
    Jones S; Zhang X; Parsons DW; Lin JC; Leary RJ; Angenendt P; Mankoo P; Carter H; Kamiyama H; Jimeno A; Hong SM; Fu B; Lin MT; Calhoun ES; Kamiyama M; Walter K; Nikolskaya T; Nikolsky Y; Hartigan J; Smith DR; Hidalgo M; Leach SD; Klein AP; Jaffee EM; Goggins M; Maitra A; Iacobuzio-Donahue C; Eshleman JR; Kern SE; Hruban RH; Karchin R; Papadopoulos N; Parmigiani G; Vogelstein B; Velculescu VE; Kinzler KW
    Science; 2008 Sep; 321(5897):1801-6. PubMed ID: 18772397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mismatch repair and immune checkpoint protein profile with histopathological parameters in pancreatic, periampullary/ampullary, and choledochal adenocarcinomas.
    Aydın AH; Turhan N
    World J Gastrointest Oncol; 2024 Mar; 16(3):875-882. PubMed ID: 38577456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Ampullary Dilatations, Etc.
    Chic Med J Exam; 1888 Sep; 57(3):186. PubMed ID: 37619079
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling.
    Werner J; Bernhard P; Cosenza-Contreras M; Pinter N; Fahrner M; Pallavi P; Eberhard J; Bronsert P; Rückert F; Schilling O
    Neoplasia; 2023 Feb; 36():100871. PubMed ID: 36610378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors.
    Weidemann S; Gagelmann P; Gorbokon N; Lennartz M; Menz A; Luebke AM; Kluth M; Hube-Magg C; Blessin NC; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Izbicki JR; Jansen K; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech RH; Dum D; Krech T; Marx AH; Simon R
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Changes Accompanying the Duodenal Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis.
    Thiruvengadam SS; OʼMalley M; LaGuardia L; Lopez R; Wang Z; Shadrach BL; Chen Y; Li C; Veigl ML; Barnholtz-Sloan JS; Pai RK; Church JM; Kalady MF; Walsh RM; Burke CA
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00053. PubMed ID: 31211760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalable MSC-derived bone tissue modules: In vitro assessment of differentiation, matrix deposition, and compressive load bearing.
    Miles KB; Maerz T; Matthew HWT
    Acta Biomater; 2019 Sep; 95():395-407. PubMed ID: 30654211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
    Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
    Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Molecular Pathologic Characteristics of Pancreatic Adenocarcinoma between Egyptian and Moroccan Patients.
    Robinson S; Soliman A; Karkouri M; Omer HG; Greenson JF
    Middle East J Cancer; 2010 Jan; 1(1):27-36. PubMed ID: 25598952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.